Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder

Thrombosis and Haemostasis

Volumn 107, Issue 4, 2012, Pages 726-734

  Hayward, Catherine P M ^a,b   Moffat, Karen A ^a,b   Castilloux, Jean Francois ^b   Liu, Yang ^a   Seecharan, Jodi ^b   Tasneem, Subia ^a   Carlino, Stephen ^b   Cormier, Anik ^c   Rivard, Georges E ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Clinical studies; Inherited acquired platelet disorders; Inherited acquired platelet pathology

Indexed keywords

15 HYDROXY 11ALPHA, 9ALPHA EPOXYMETHANOPROSTA 5, 13 DIENOIC ACID; ADENOSINE TRIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; CHRONOLUME; COLLAGEN; FIREFLY LUCIFERASE; LUCIFERIN; MAGNESIUM; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; PRIORITY JOURNAL; QUEBEC PLATELET DISORDER; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BENZOTHIAZOLES; BLOOD PLATELETS; CASE-CONTROL STUDIES; EPINEPHRINE; FACTOR V DEFICIENCY; HUMANS; INDICATORS AND REAGENTS; LIGHT; LUCIFERASES; MAGNESIUM; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TIME FACTORS;

EID: 84859322306     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th11-10-0740     Document Type: Article

References (25)

1. Hayward CP. Diagnostic evaluation of platelet function disorders. Blood Rev 2011; 25: 169-173.
2. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009; 35: 158-167.
3. Pai M, Hayward CP. Diagnostic assessment of platelet disorders: what are the challenges to standardization? Semin Thromb Hemost 2009; 35: 131-138.
4. Quiroga T, Goycoolea M, Matus V, et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol 2009; 147: 729-736.
5. Hayward CP, Pai M, Liu Y, et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 2009; 7: 676-684.
6. Castilloux JF, Moffat KA, Liu Y, et al. A prospective, cohort study of light transmission platelet aggregometry for bleeding disorders: Is testing native platelet rich plasma non-inferior to testing platelet count adjusted samples? Thromb Haemost 2011; 106: 675-682.
7. Pai M, Wang G, Moffat KA, et al. Diagnostic usefulness of a lumiaggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 2011; 136: 350-358.
8. Cattaneo M, Hayward CP, Moffat KA, et al. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009; 7: 1029.
9. Christie DJ, Avari T, Carrington LR, et al. Clinical and Laboratory Standards Institute (CLSI). Platelet function testing by aggregometry; approved guideline. CLSI document H58-A (ISBN 1-56238-683-2). Clinical and Laboratory Standards Institute, Wayne, PA, USA 2008; 28 (31): Available at: http://www.clsi.org. Assessed May 31, 2011.
10. McGlasson DL, Fritsma GA. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Haemost 2009; 35:168-180.
11. Callan MB, Shofer Frances S, et al. Chrono-lume® and magnesium potentiate aggregation of canine but not human platelets in citrated platelet-rich plasma. Thromb Haemost 1998; 80: 176-180.
12. Mehta P, Mehta JL, Aguila E. Platelet aggregation. Blood 1983, 62: 1151.
13. Mehta P, Mehta J, Ostrowski N, et al. Potentiation of platelet aggregation by CHRONOLUME®. Thromb Res 1983; 32: 509-512.
14. Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134: 955-963.
15. Hayward CP, Rivard GE. Quebec platelet disorder. Expert Rev Hematol 2011; 4: 137-141.
16. Blavignac J, Bunimov N, Rivard GE, et al. Quebec platelet disorder: Update on pathogenesis, diagnosis and treatment. Semin Thromb Haemost 2011; 37: 713-720.
17. Paterson AD, Rommens JM, Bharaj B, et al. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood 2010; 115: 1264-1266.
18. Hayward CP, Moffat KA, Pai M, et al. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost 2008; 100: 134-145.
19. Thompson NT, Scrutton MC. Inhibition by luciferin-luciferase reagents of aggregation responses to excitatory agonists in washed platelet suspensions. Thromb Res 1985; 28: 109-119.
20. Noda L, Nihei T, Morales MF. The enzymatic activity and inhibition of adenosine 5'-triphosphate-creatine transphosphorylase. J Biol Chem 1960; 235: 2830-2834.
21. Pesho MM, Bledzka K, Michalec L, et al. The specificity and function of the metalbinding sites in the integrin beta3 A-domain. J Biol Chem. 2006; 281: 23034-23041.
22. Yamniuk AP, Vogel HJ. Calcium- and magnesium-dependent interactions between calcium- and integrin-binding protein and the integrin alphaIIb cytoplasmic domain. Protein Sci 2005; 16: 1429-1437.
23. Yamniuk AP, Nguyen LT, Hoang TT, et al. Metal ion binding properties and conformational states of calcium- and integrin-binding protein. Biochemistry 2004; 43: 2558-2568.
24. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-158.
25. Ingerman-Wojenski CM, Silver MJ. A quick method for screening platelet dysfunctions using the whole blood-aggregometer. Thromb Haemost 1984; 51: 154-156.